Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-04991532 and Sitagliptin in T2DM
NCT01336738Phase 2Completed
- Sponsor
- Pfizer
- Start
- Jun 2011
- Primary completion
- Mar 2012
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 2 trial of PF-04991532 in type 2 diabetes mellitus (T2DM), sponsored by Pfizer. Started Jun 2011; status: completed.
02
Drugs
PF-04991532
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01336738.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01336738.